OZANIMOD AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRUE NORTH STUDY

Silvio Danese  1     Brian G. Feagan  2     Douglas C. Wolf  3     Stephen B Hanauer  4     Igor Jovanovic  5     Subrata Ghosh  6     AnnKatrin Petersen  7     Steven Y Hua  7     Ji Hwan Lee  7     Lorna Charles  7     Denesh Chitkara  7     William Sandborn  8     Geert R. D'Haens  9    
1 Humanitas Clinical and Research Center, Milan, Italy
2 Western University, London, Canada
3 Atlanta Gastroenterology Associates, Atlanta, United States
4 Feinberg School of Medicine, Chicago, United States
5 University Hospital Medical Centre Bezanijska Kosa, Belgrade, Serbia
6 University of Calgary, Alberta, Canada
7 Bristol-Myers Squibb Company, Princeton, United States
8 University of California San Diego, La Jolla, United States
9 Amsterdam University Medical Center, Amsterdam, Netherlands

Session
Late breaking abstract: Clinical IBD highlights

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing